Finding accredited CPD
The prospect of rapid translation of research on health policy through living evidence has been embraced globally, with the World Health Organization, Cochrane, Pan American Health Organization, United States Government, and National Institute for Health and Care Excellence all committing to adopting living evidence approaches. However, the use of living evidence to date has been focused primarily on discrete clinical areas, such as treatments for stroke and coronavirus disease 2019 (COVID‐19).
We believe there is an opportunity to realise the substantial potential benefits of living evidence for health systems, and to lead this field internationally by co‐creating mechanisms and strengthening knowledge translation architecture to encourage living evidence use in health policy. A critical early step in realising this ambition is to establish an Australian research agenda to understand and advance living evidence for policy.
This MJA Perspective shares more.
Authors: Samantha P Chakraborty, Alex Collie, Rebecca Hodder, Suman S Majumdar, Kim Sutherland, Bernie Towler, Joshua Vogel, Andrew Wilson, Luke Wolfenden, Sally Green and Tari Turner
Article Type: Perspective
Provided by
Educational Activities (EA) - 0.30
Reviewing Performance (RP) - 0.0
Measuring Outcomes (MO) - 0.0
You have to log in to see the content of this module.
*Medical Board of Australia’s (MBA)’s revised Registration Standard: Continuing professional development (the Standard)
